KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Other Gross PP&E Adjustments (2016 - 2026)

Bristol Myers Squibb has reported Other Gross PP&E Adjustments over the past 18 years, most recently at -$1.5 billion for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments fell 44.97% to -$1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.5 billion through Mar 2026, down 44.97% year-over-year, with the annual reading at -$1.6 billion for FY2025, 48.82% down from the prior year.
  • Other Gross PP&E Adjustments was -$1.5 billion for Q1 2026 at Bristol Myers Squibb, up from -$1.6 billion in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$678.0 million in Q2 2022 and troughed at -$1.6 billion in Q4 2025.
  • The 5-year median for Other Gross PP&E Adjustments is -$1.2 billion (2024), against an average of -$1.1 billion.
  • Year-over-year, Other Gross PP&E Adjustments increased 19.0% in 2022 and then tumbled 67.13% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.1 billion in 2022, then dropped by 16.07% to -$1.2 billion in 2023, then increased by 13.44% to -$1.1 billion in 2024, then crashed by 48.82% to -$1.6 billion in 2025, then grew by 3.41% to -$1.5 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Other Gross PP&E Adjustments are -$1.5 billion (Q1 2026), -$1.6 billion (Q4 2025), and -$1.4 billion (Q3 2025).